Emerging Infectious Diseases (Apr 2016)

Evaluation of Viremia Frequencies of a Novel Human Pegivirus by Using Bioinformatic Screening and PCR

  • David Bonsall,
  • William F. Gregory,
  • Camilla L.C. Ip,
  • Sharyne Donfield,
  • James Iles,
  • M. Azim Ansari,
  • Paolo Piazza,
  • Amy Trebes,
  • Anthony Brown,
  • John Frater,
  • Oliver G. Pybus,
  • Phillip Goulder,
  • Paul Klenerman,
  • Rory Bowden,
  • Edward D. Gomperts,
  • Eleanor Barnes,
  • Amit Kapoor,
  • Colin P. Sharp,
  • Peter Simmonds

DOI
https://doi.org/10.3201/eid2204.151812
Journal volume & issue
Vol. 22, no. 4
pp. 671 – 678

Abstract

Read online

Next-generation sequencing has critical applications in virus discovery, diagnostics, and environmental surveillance. We used metagenomic sequence libraries for retrospective screening of plasma samples for the recently discovered human hepegivirus 1 (HHpgV-1). From a cohort of 150 hepatitis C virus (HCV)–positive case-patients, we identified 2 persons with HHpgV-1 viremia and a high frequency of human pegivirus (HPgV) viremia (14%). Detection of HHpgV-1 and HPgV was concordant with parallel PCR-based screening using conserved primers matching groups 1 (HPgV) and 2 (HHPgV-1) nonstructural 3 region sequences. PCR identified 1 HHPgV-1–positive person with viremia from a group of 195 persons with hemophilia who had been exposed to nonvirally inactivated factor VII/IX; 18 (9%) were HPgV-positive. Relative to HCV and HPgV, active infections with HHpgV-1 were infrequently detected in blood, even in groups that had substantial parenteral exposure. Our findings are consistent with lower transmissibility or higher rates of virus clearance for HHpgV-1 than for other bloodborne human flaviviruses.

Keywords